2022 American College of Rheumatology (ACR) Guideline for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases      D064A5AD64D848FEC553AA8136BD6112 10.1002/acr.25045  Conclusion: Application of these recommendations should take into consideration patients' individual risk for vaccine-preventable illness and for disease flares, particularly if immunosuppressive medications are held for vaccination. Shared decision-making with patients is encouraged in clinical settings. Expanded indications for specific vaccines in patients with RMDs on immunosuppression For RMD patients aged â‰¥ 65 years, and RMD patients aged >18 and <65 years who are on immunosuppressive medication, giving high-dose or adjuvanted influenza vaccination is conditionally recommended over giving regular-dose influenza vaccination. For patients with RMD aged <65 years who are on immunosuppressive medication, pneumococcal vaccination is strongly recommended. For patients with RMD aged >18 years who are